Founded with a vision to leverage plasma science for a cleaner world, AAPlasma focuses on developing non-equilibrium atmospheric pressure plasma catalysts. The company's core mission is to innovate cold plasma technology to provide rapid and efficient decontamination solutions, particularly for personal protective equipment (PPE). By enabling in-between-patient decontamination, AAPlasma aims to facilitate the rapid reuse of PPE items, addressing critical needs in healthcare and other sectors.
AAPlasma has garnered attention for its groundbreaking approach to decontamination, attracting notable investors and industry experts. The company’s technology is built on previously successful systems, underscoring its potential for significant impact. Through its innovative solutions, AAPlasma is contributing to more sustainable practices in healthcare and beyond, reducing waste and enhancing safety.
